Skip to main content
Egyptian Liver Journal

Table 3 Laboratory results of the studied groups

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

 

Cirrhosis group

N=50

HCC group

N=50

Test of significance

INR

1.49±0.37

1.29±0.34

t=2.68

p=0.009*

Albumin (g/dl)

3.12±0.49

2.83±0.77

t=2.29

p=0.024*

AST (IU/ml)

55.70±37.29

95.0±73.97

z=3.21

p=0.001*

ALT (IU/ml)

46.50±24.52

60.22±41.63

z=1.44

p=0.149

Platelet/cm (×  103)

106.22±42.06

88.02±39.54

z=2.23

p=0.001*

WBCs/cm

5.74±2.61

6.44±2.96

z=1.18

p=0.235

Hgb (g/dl)

9.11±0.97

9.71±1.73

t=2.12

p=0.036*

Creatinine (mg/dl)

1.11±0.37

1.18±0.49

t=0.851

p=0.397

Total bilirubin (mg/dl)

2.76±2.7

5.09±5.27

z=2.82

p=0.005*

Direct bilirubin (mg/dl)

1.67±2.06

3.15±3.6

z=2.19

p=0.028*

  1. *Statistically significant (if p< 0.05)
Back to article page